UB Paderborn / Katalog / Suche / in CDI

Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

Obesity surgery, 2016-08, Vol.26 (8), p.1659-1696

2016

Link zum Volltext

Verfügbarkeit prüfen

Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer

Scientific reports, 2023-12, Vol.13 (1), p.21262-21262, Article 21262

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer

Genome medicine, 2021-05, Vol.13 (1), p.85-85, Article 85

2021

Link zum Volltext

Verfügbarkeit prüfen

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review

Breast (Edinburgh), 2021-06, Vol.57, p.95-103

2021

Link zum Volltext

Verfügbarkeit prüfen

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

International journal of cancer, 2019-10, Vol.145 (8), p.2114-2121

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy

Strahlentherapie und Onkologie, 2017, Vol.193 (1), p.62-69

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial

The lancet oncology, 2018-07, Vol.19 (7), p.987-998

2018

Link zum Volltext

Verfügbarkeit prüfen

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1054-1062

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer

Reviews on recent clinical trials, 2017-01, Vol.12 (2), p.67

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term quality of life after breast surgery-are breast conserving surgery and mastectomy comparable?

Gland surgery, 2024-03, Vol.13 (3), p.452-454

2024

Link zum Volltext

Verfügbarkeit prüfen

Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence

Anticancer research, 2023-02, Vol.43 (2), p.733

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

Reviews on recent clinical trials, 2017-01, Vol.12 (2), p.93

2017

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

European journal of cancer (1990), 2023-05, Vol.184, p.1-9

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

Drug safety, 2020-03, Vol.43 (3), p.233-242

2020

Link zum Volltext

Verfügbarkeit prüfen

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

Breast cancer research and treatment, 2023-12, Vol.202 (3), p.497-504

2023

Link zum Volltext

Verfügbarkeit prüfen

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

Journal of clinical oncology, 2021-05, Vol.39 (15), p.1619-1630

2021

Link zum Volltext

Verfügbarkeit prüfen

Axillary surgery in the case of limited involved axillary lymph nodes

Gland surgery, 2023-06, Vol.12 (6), p.727-729

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation

Anticancer research, 2019-08, Vol.39 (8), p.4215-4218

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars

Oncotarget, 2019-01, Vol.10 (1), p.8-9

2019

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts

Breast care (Basel, Switzerland), 2016-08, Vol.11 (4), p.275-281

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer

Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

Long-term quality of life after breast surgery-are breast conserving surgery and mastectomy comparable?

Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

Axillary surgery in the case of limited involved axillary lymph nodes

Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial

Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars

Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts

Suchergebnisse filtern